Hanseatic Management Services Inc. Makes New $307,000 Investment in FactSet Research Systems Inc. (NYSE:FDS)

Hanseatic Management Services Inc. bought a new position in FactSet Research Systems Inc. (NYSE:FDS) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 1,071 shares of the business services provider’s stock, valued at approximately $307,000.

Other hedge funds also recently modified their holdings of the company. Global Retirement Partners LLC grew its stake in FactSet Research Systems by 114.0% in the 4th quarter. Global Retirement Partners LLC now owns 199 shares of the business services provider’s stock worth $40,000 after acquiring an additional 106 shares in the last quarter. First Mercantile Trust Co. grew its stake in FactSet Research Systems by 138.3% in the 1st quarter. First Mercantile Trust Co. now owns 336 shares of the business services provider’s stock worth $83,000 after acquiring an additional 195 shares in the last quarter. Icon Wealth Partners LLC bought a new position in FactSet Research Systems in the 1st quarter worth about $84,000. Liberty Wealth Management LLC bought a new position in FactSet Research Systems in the 4th quarter worth about $68,000. Finally, Marshall Wace LLP bought a new position in FactSet Research Systems in the 1st quarter worth about $85,000. Institutional investors and hedge funds own 93.84% of the company’s stock.

In related news, insider Brian G. Daly sold 473 shares of the stock in a transaction that occurred on Thursday, July 11th. The shares were sold at an average price of $294.17, for a total transaction of $139,142.41. Following the completion of the sale, the insider now owns 735 shares of the company’s stock, valued at $216,214.95. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Philip A. Hadley sold 25,000 shares of the stock in a transaction that occurred on Friday, July 19th. The shares were sold at an average price of $285.60, for a total transaction of $7,140,000.00. Following the sale, the director now directly owns 542,368 shares of the company’s stock, valued at approximately $154,900,300.80. The disclosure for this sale can be found here. Insiders have sold 73,128 shares of company stock valued at $21,146,041 in the last three months. 2.30% of the stock is currently owned by corporate insiders.

Shares of NYSE FDS traded up $4.33 during midday trading on Wednesday, reaching $280.75. 117,692 shares of the company’s stock traded hands, compared to its average volume of 348,081. The company has a debt-to-equity ratio of 0.88, a quick ratio of 2.87 and a current ratio of 2.87. The stock’s 50 day moving average is $290.06. FactSet Research Systems Inc. has a one year low of $188.31 and a one year high of $305.38. The stock has a market cap of $10.67 billion, a P/E ratio of 32.91, a price-to-earnings-growth ratio of 2.79 and a beta of 1.01.

FactSet Research Systems (NYSE:FDS) last released its quarterly earnings data on Tuesday, June 25th. The business services provider reported $2.62 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.37 by $0.25. FactSet Research Systems had a net margin of 23.30% and a return on equity of 64.19%. The firm had revenue of $364.50 million for the quarter, compared to the consensus estimate of $359.25 million. During the same period last year, the firm earned $2.18 earnings per share. The company’s quarterly revenue was up 7.2% on a year-over-year basis. Equities analysts predict that FactSet Research Systems Inc. will post 9.86 EPS for the current fiscal year.

A number of equities analysts have commented on FDS shares. Stifel Nicolaus upped their target price on shares of FactSet Research Systems from $230.00 to $242.00 and gave the stock a “hold” rating in a research note on Wednesday, June 26th. Credit Suisse Group reiterated a “hold” rating on shares of FactSet Research Systems in a research note on Monday, July 8th. Morgan Stanley dropped their price objective on shares of Neon Therapeutics from $19.00 to $13.00 and set an “overweight” rating on the stock in a research note on Tuesday, July 16th. UBS Group set a $13.00 price objective on shares of Freeport-McMoRan and gave the company a “hold” rating in a research note on Wednesday, June 26th. Finally, Goldman Sachs Group upgraded shares of to a “neutral” rating and dropped their price objective for the company from GBX 1,855 ($24.24) to GBX 1,800 ($23.52) in a research note on Thursday, June 27th. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $251.69.

FactSet Research Systems Company Profile

FactSet Research Systems Inc provides integrated financial information and analytical applications to the investment community in the United States, Europe, and the Asia Pacific. The company delivers insight and information to financial investment professionals through its analytics, services, contents, and technologies.

See Also: Blockchain

Institutional Ownership by Quarter for FactSet Research Systems (NYSE:FDS)

Receive News & Ratings for FactSet Research Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FactSet Research Systems and related companies with MarketBeat.com's FREE daily email newsletter.